A 4-year-old child with a history of cystic fibrosis (CF) presents to the clinic for a routine follow-up. The parents report that the child has had an increase in productive cough, wheezing, and shortness of breath over the past few days. Upon examination, the child has clubbed fingers, and chest auscultation reveals decreased breath sounds. Given these findings, which of the following interventions should the nurse prioritize to manage the child's condition and prevent further respiratory complications?

A. EMLA cream is a pharmacologic intervention because it contains local anesthetics (lidocaine and prilocaine) that numb the skin. It must be applied 30–60 minutes before the procedure under an occlusive dressing to achieve effective analgesia. Applying it immediately before a heel stick would not provide pain relief and does not qualify as nonpharmacologic.

B. Intramuscular opioids are systemic pharmacologic agents used for moderate to severe pain. They carry risks such as respiratory depression, sedation, and hypotension in neonates, so they are rarely used for minor procedures like heel sticks.

C. Distraction with toys or verbal explanations is ineffective for neonates because infants at 2 days old cannot process or respond to visual or verbal cues. Cognitive engagement strategies work only in older infants and children.

D. Oral sucrose combined with nonnutritive sucking (e.g., using a pacifier) is a safe and evidence-based nonpharmacologic method for reducing procedural pain in neonates. Sucrose triggers the release of endogenous opioids in the central nervous system, which decreases the perception of pain. Nonnutritive sucking provides comfort and a calming effect, further reducing physiological stress responses such as increased heart rate, blood pressure, and crying. Studies show that this intervention effectively lowers behavioral and physiological indicators of pain during minor procedures such as heel sticks, venipuncture, or immunizations. This method is preferred for routine procedures in neonates because it is simple, safe, and effective without the risks associated with pharmacologic agents.

A. Pre-eclampsia is usually associated with oliguria (reduced urine output) due to renal vasoconstriction and decreased glomerular filtration. Polyuria is not expected and may indicate another condition, such as diabetes mellitus.

B. While mild increases in heart rate can occur, tachycardia is not a hallmark sign of pre-eclampsia. Blood pressure elevation, rather than heart rate changes, is the primary cardiovascular finding.

C. Severe pre-eclampsia is characterized by hypertension with systemic involvement, and persistent, severe headaches are common due to cerebral edema and vasospasm. Headaches are a classic symptom and often a warning sign for potential complications such as eclampsia.

D. Visual disturbances can occur in pre-eclampsia (e.g., blurred vision, scotomata, or spots), but diplopia (double vision) is less common. Headache is a more consistent and expected finding in severe pre-eclampsia.